Skip to main content

Solid Biosciences Inc. (SLDB)

Sector
Biotechnology
Last price
$6.48
As of

Kresmion compiles this page from SLDB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Solid Biosciences Inc. (SLDB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-04.

As of . Source: SEC EDGAR filings for SLDB. Method and limitations.

COMPANY DOSSIER

See the full SLDB dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for SLDB on one page. Preview it with sample data, then open it live with a free account.

Preview the SLDB dossier

Active events for SLDB

FREE, NO ACCOUNT

Every event on SLDB, as it fires

You are seeing 5 of 6 events recorded on SLDB since 2026-08-11.

The five above landed across 2 days. The other 1 were recorded on 1 other days. 4 of the 6 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, SLDB

More data on SLDB

SLDB against its peers

SLDB's return on equity of -96.8% ranks in the 32nd percentile of 19 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.

MetricSLDBPeer medianPercentilen
Revenue FYn/a83.3Mn/a12
Operating marginn/a-114.2%n/a12
Net marginn/a-120.7%n/a12
Return on equity-96.8%-45.8%3319
1 year44.6%-3.8%8320

Peers (21): ANNX, PRME, LXRX, ARDX, JANX, GLUE, IRWD, SGMT, XOMA.D, SNDX, SANA, RIGL, NVCT, ACHV, MGTX, DBVT, AVBP, FDMT, OLMA, CRVS, ORIC. Left out: OBX (no annual filing), LTGO (no annual filing), ATTO (no annual filing), BBTX (no annual filing). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (SLDB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in SLDB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on SLDB in the last 180 days.

Upstream: SEC EDGAR filings for SLDB

Kresmion, "Solid Biosciences Inc. (SLDB) institutional holdings and SEC filings", data as of 2026-11-12, https://kresmion.com/research/SLDB. Upstream data: SEC EDGAR filings for SLDB.

Link to this data (HTML):

<a href="https://kresmion.com/research/SLDB">Solid Biosciences Inc. (SLDB) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow SLDB on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to SLDB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the SLDB dossier
Share

The SLDB intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.